摘要
随着靶向治疗时代的到来,新的实体瘤评价标准如改良的实体瘤反应评价标准、正电子发射断层扫描反应标准、Choi 标准和免疫相关反应标准相继出现。血清标志物和循环肿瘤细胞等也用于临床反应的评价。这些指标为肿瘤疗效评价提供了有力的工具。
With the coming era of targeted therapy,novel criteria such as the modified response evalu-ation criteria in solid tumors (RECIST),positron emission tomography response criteria in solid tumors (PETRCIST),Choi criteria and immune-related response criteria have been proposed as standardized methods to assess therapeutic response.Biomarkers and circulating tumor cells may be considered suitable for the evalu-ation of response.These criteria may be useful for the evaluation of therapeutic response to tumors.
作者
张百红
岳红云
Zhang Baihong Yue Hongyun(Department of Oneology, Lanzhou General Hospital of Lanzhou Military Region, Lanzhou 730050, Chin)
出处
《国际肿瘤学杂志》
CAS
2016年第11期845-847,共3页
Journal of International Oncology
基金
甘肃省自然科学基金(1308RJZA181)
关键词
肿瘤
药物评价
反应评价标准
分子靶向治疗
Neoplasms
Durg evaluation
Response evaluation criteria
Molecular targeted therapy